13F Data
13F filer · CIK 1318153

Mayo Clinic

Rochester, MN · filing since Q4 2019 · last filing Nov 12, 2024
Reported value
$2.9M
$-127.8K vs prior
Positions
3
New / sold out
0 / 1
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $190.1K
Top-10 weight
100.0%

Biggest buys vs Q2 2024

No new or increased positions this quarter.

Biggest sells vs Q2 2024

ChangeSecurityShares changeChange %Est. trade value
Sold outNeuroone Medical Technologies-181,754-100.0%$-145.4K
ReducedZentalis Pharmaceuticals Inc-12,143-6.5%$-44.7K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $88.2MQ1 2020: $39.5MQ2 2020: $104.5MQ3 2020: $74.2MQ4 2020: $83.1MQ1 2021: $86.9MQ2 2021: $90.4MQ4 2022: $188.8MQ1 2023: $121.8MQ2 2023: $97.4MQ3 2023: $51.9MQ4 2023: $16.2MQ1 2024: $6.1MQ2 2024: $3.0MQ3 2024: $2.9M
Q4 2019Q3 2024

Holdings · Q3 2024

#SecuritySharesValueWeight
1ISHARES TRMSCI ACWI ETF17,359$2.1M71.52%
2Zentalis Pharmaceuticals IncCOMMON175,000$644.0K22.19%
3UNITY BIOTECHNOLOGY INCCOMMON124,081$182.4K6.29%